Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease

NCT04455555 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

294

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: LY03003( the name of rotigotine)
OTHER: Placebo

Sponsor

Peking University Third Hospital